Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 196 entries
View as:

Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

Phase: N/A Priority: Normal
NCT ID: NCT04133012 Org: User:
Start: 02/10/20 End: 06/09/23 Due: 06/09/24

Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection

Phase: N/A Priority: Normal
NCT ID: NCT02125500 Org: User:
Start: 08/31/14 End: 12/31/15 Due: 12/31/16

Expectation, Motivation and Experience of HIV-patients Regarding Participation to an HIV Cure-related Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT05280392 Org: User:
Start: 06/21/22 End: 03/30/23 Due: 03/30/24

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV

Phase: N/A Priority: Normal
NCT ID: NCT00901524 Org: User:
Start: 06/30/09 End: 06/30/12 Due: 06/30/13

Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection

Phase: N/A Priority: Normal
NCT ID: NCT04863547 Org: User:
Start: 03/11/21 End: 05/31/21 Due: 05/31/22

Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir

Phase: N/A Priority: Normal
NCT ID: NCT02647632 Org: User:
Start: 01/31/16 End: 04/30/17 Due: 04/30/18

Cohort of HIV Associated Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT01164436 Org: User:
Start: 06/30/08 End: 06/30/17 Due: 06/30/18

Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT02826447 Org: User:
Start: 02/21/17 End: 04/30/18 Due: 04/30/19

EBOla Post-Exposure Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT06841614 Org: User:
Start: 05/01/25 End: 12/01/27 Due: 12/01/28

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders

Phase: N/A Priority: Normal
NCT ID: NCT01725542 Org: User:
Start: 12/31/12 End: 06/30/14 Due: 06/30/15

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

Phase: N/A Priority: Normal
NCT ID: NCT05590455 Org: User:
Start: 04/11/23 End: 06/30/27 Due: 06/30/28

Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV

Phase: N/A Priority: Normal
NCT ID: NCT03869944 Org: User:
Start: 12/04/19 End: 03/31/22 Due: 03/31/23

Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS

Phase: N/A Priority: Normal
NCT ID: NCT02624453 Org: User:
Start: 07/31/15 End: 03/31/18 Due: 03/31/19

Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)

Phase: N/A Priority: Normal
NCT ID: NCT01033760 Org: User:
Start: 04/30/10 End: 12/31/13 Due: 12/31/14

Aging With HIV and Neurocognitive Decline, a Follow-up Study

Phase: N/A Priority: Normal
NCT ID: NCT05385588 Org: User:
Start: 11/14/22 End: 02/01/24 Due: 02/01/25

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

Phase: N/A Priority: Normal
NCT ID: NCT04120415 Org: User:
Start: 06/21/22 End: 07/12/23 Due: 07/12/24

Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence

Phase: N/A Priority: Normal
NCT ID: NCT01509508 Org: User:
Start: 03/31/12 End: 06/30/16 Due: 06/30/17

Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa

Phase: N/A Priority: Normal
NCT ID: NCT01715922 Org: User:
Start: 05/31/12 End: 09/30/16 Due: 09/30/17

Frailty in People Living With HIV Aged 70 Years or More

Phase: N/A Priority: Normal
NCT ID: NCT03958786 Org: User:
Start: 05/15/19 End: 06/22/24 Due: 06/22/25

Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)

Phase: N/A Priority: Normal
NCT ID: NCT02247687 Org: User:
Start: 12/31/14 End: 09/30/15 Due: 09/30/16

Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)

Phase: N/A Priority: Normal
NCT ID: NCT01331811 Org: User:
Start: 04/30/11 End: 05/31/14 Due: 05/31/15

Lowering InterLeukin-1 Receptor Antagonist Concentrations After TB Treatment Onset

Phase: N/A Priority: Normal
NCT ID: NCT04015713 Org: User:
Start: 01/21/20 End: 03/31/21 Due: 03/31/22

Prevalence of Histoplasmosis in HIV + Patients with a Rapid Diagnostic Test in West Indies

Phase: N/A Priority: Normal
NCT ID: NCT01884779 Org: User:
Start: 08/31/13 End: 11/03/15 Due: 11/03/16

Cohort of Patients Naive of Antiretroviral Treatment at Enrollment

Phase: N/A Priority: Normal
NCT ID: NCT03137797 Org: User:
Start: 02/29/04 End: 06/30/16 Due: 06/30/17

Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa

Phase: N/A Priority: Normal
NCT ID: NCT02025868 Org: User:
Start: 03/31/13 End: 05/31/17 Due: 05/31/18